GHRL and Insulin resistance: Ghrelin infusion induced peripheral insulin resistance, as assessed by the GIR, independently of acipimox (P = 0.02), whereas acipimox improved peripheral insulin sensitivity independently of ghrelin (P = 0.005, Fig. 3a and b).